Business
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) CEO Erez Vigodman said today, “If the Mylan Pharmaceuticals shareholders support the acquisition of...
Hi, what are you looking for?
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) CEO Erez Vigodman said today, “If the Mylan Pharmaceuticals shareholders support the acquisition of...
Erez Vigodman: Size isn't everything; it's important to be better.
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has completed first step to buy its rival Mylan N.V. (Nasdaq: MYL). The Israeli giant announced...
Teva says it will seek ‘further appellate review’
Teva is now close to the 4.6% stake in Mylan that will give it standing in the Netherlands courts.
Mylan has confirmed it will dual list on the TASE and Nasdaq if it acquires Perrigo
XIO is paying a 16% premium on the share price of the Israeli medical device company.
– – Israel’s Biogal Galed Labs, a global provider of veterinary diagnostic solutions, has announced the commercialization of two new PCRun Veterinary Molecular Detection...
Allergan PLC, the Botox maker to treat wrinkles, agreed to buy Kythera Biopharmaceuticals Inc.,
Abbott Laboratories (NYSE: ABT), said it would back the generic pharmaceutical company Mylan’s (MYL) $34 billion bid acquisition of Perrigo Co Plc (PRGO.N). Abbott...